FDA Approves Gene Therapy for Severe Pediatric LAD-I - Top_Thought_Leaders - MDSpire

FDA Approves Gene Therapy for Severe Pediatric LAD-I

Approval expands treatment option for a rare pediatric immunodeficiency

  • By

  • Kathryn Wighton

  • March 27, 2026

  • 2 min

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

FDA Approves Gene Therapy for Severe Pediatric LAD-I

  • by Kathryn Wighton

  • March 27, 2026

Related Content

Advancements in diagnosis, preventive care, and future directions in the holistic management of pediatric asthma

Error in Results

  • May 22, 2026

The optimal exercise for improving inhibitory control in children and adolescents with NDDs: a systematic review and network meta-analysis